Drugs / allogenic adipose stem cell
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02298023 | Sep 2014 → Jul 2016 | rotator cuff syndrome | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogenic adipose stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02298023 ↗ |
| Modality | Cell therapy | “allogenic adipose-derived mesenchymal stem cells” NCT02298023 ↗ |
| Route | Other | “allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by...” NCT02298023 ↗ |